Background The outcomes in patients by visual assessment and quantitative coronary angiography (QCA) for obstructive coronary artery disease (CAD) are not known. Our objectives were to compare visual and QCA estimates of obstructive CAD and to assess their relationship to outcomes in stable patients with symptoms of CAD.
Background
Since the introduction of coronary angiography, visual estimation of the degree of coronary artery narrowing has been the routine method for determining coronary stenosis severity clinically. However, this method is limited by intraobserver and interobserver variability, [1] [2] [3] observer bias, and significant discordance between visual estimates of coronary artery luminal narrowing and functional significance of stenoses. 4 Quantitative coronary angiography (QCA), first described almost 40 years ago, 5 uses computer-based quantitation and may overcome some of the limitations of visual stenosis estimation including observer variability. 6 Studies comparing QCA to visual estimation suggest that visual estimation may "overestimate" lesion severity, [7] [8] [9] [10] [11] although this conclusion assumes QCA as the criterion standard. Given such disagreements, it is possible that visual estimation of stenosis and QCA may differ in the clinically important task of prediction of patient outcomes, but this has not been studied.
The objectives of this substudy of the PROMISE trial 12 were to determine the rate of agreement and disagreement between visually estimated stenosis and QCA of coronary angiography for obstructive coronary artery disease (CAD), and to compare results from each method to patient outcomes in stable patients presenting with symptoms of CAD.
Methods
The methods and results of the PROMISE trial have been previously reported. 12, 13 Briefly, PROMISE was a pragmatic randomized controlled trial conducted at 193 participating sites in the United States and Canada in which stable symptomatic outpatients without known CAD were randomized to receive either functional testing (exercise electrocardiogram, stress echocardiogram, or nuclear stress test) or anatomical testing (coronary computed tomographic angiography [CTA] ). 12 All initial tests were performed and interpreted by local physicians at the participating sites, and all additional diagnostic or therapeutic procedures, including performing invasive coronary angiography, were left to the discretion of the patient's physician. All patients were followed up for the primary end point of death, myocardial infarction (MI), unstable angina hospitalization, or complications from procedures. The PROMISE trial found no difference in these clinical events over a median 25 months of follow-up with either an initial noninvasive anatomic testing strategy with CTA or a functional testing strategy.
Population included in this substudy
This substudy includes patients in PROMISE who received an invasive coronary angiogram as part of their diagnostic work-up. Sites were required to upload images of the angiograms performed on study patients into a central database and provide the catheterization report detailing visually read results of the angiogram. The final population used in this analysis included patients for whom both a site report detailing visually read results and a corresponding site-uploaded angiogram for QCA were available. For patients who underwent multiple catheterizations, only the initial diagnostic catheterization was included in the analysis.
Site quantification of coronary stenosis
At each study site, stenosis was visually assessed and reported. Centrally, each site angiogram report was entered into the database as stenosis in the right coronary artery, left anterior descending artery (LAD), proximal LAD, and left circumflex artery, with a maximum level of stenosis categorized as follows: (1) normal (0%), (2) nonsignificant/mild or minor (1%-49%), (3) moderate (50%-69%), (4) significant/severe (70%-99%), or (5) occluded (100%). For the left main artery (LM), the maximum level of stenosis was categorized as follows: (1) normal (0%), (2) nonsignificant/mild or minor (1%-49%), (3) significant/severe (50%-99%), or (4) occluded (100%). If no assessment was recorded for an artery by the site, it was assumed to be normal.
Quantitative coronary angiography quantification of coronary stenosis "QAngio XA" postprocessing QCA software (Medis Medical Imaging Systems, Leiden, the Netherlands) was used to independently assess each angiogram in a central core laboratory at Duke. Quantitative coronary angiography was performed according to a standard protocol, in which 2 orthogonal views were assessed to measure maximum stenosis. Each angiogram was read by a minimum of 2 readers who were blinded to the results of the site report. The primary reader carefully evaluated each angiogram and performed QCA on each possibly obstructive lesion. The reviewers manually mapped the straight-line path of the artery across the lesion, which was then used by the QAngio software to determine the maximum level of stenosis. The secondary reader, a board-certified interventional cardiologist, ensured adequate quality and accuracy of the QCA.
Detailed QCA analysis was performed for the 18 coronary vessel segments, based on the Society of Cardiovascular Computed Tomography coronary segmentation.
14 For every angiogram, the maximum level of stenosis observed was reported for each of the 18 segments from the following categories: (1) 0%, (2) 1% to 29%, or (3) ≥30%. For stenosis ≥30%, the numerical value of the stenosis per QCA was reported. Only major cardiovascular vessels and side branches defined as having a diameter of at least 2 mm were included in this analysis.
Obstructive disease and outcomes definitions
Obstructive CAD in a patient was defined as the presence of 1 or more vessels with a stenosis of 50% or greater. Each patient who underwent invasive angiography was classified as having the presence or absence of obstructive disease per site-based visual estimate and per QCA analysis. The primary clinical end point of PROMI-SE-a composite of major cardiovascular events that included death from any cause, MI, hospitalization for unstable angina, and major complication of cardiovascular procedures-was assessed for each of the 4 groups (based on site and QCA agreement or disagreement). The primary end point was assessed over the entire follow-up period, starting from day of cardiac catheterization, for each patient.
Statistical analysis
Baseline characteristics are presented for all patients within the QCA population, patients in whom site and QCA agreed on the presence of obstructive disease, patients in whom site and QCA agreed on the absence of obstructive disease, and patients in whom site and QCA disagreed. Contingency tables were generated to assess agreement for obstructive disease per patient between site and QCA reads of angiograms. Disagreement rates (when site read and QCA responses differed) were tabulated, and the κ agreement statistics (with 95% CIs) were estimated. For the 4 groups defined above, cumulative clinical event rates were calculated with the Kaplan-Meier method 15 using events after catheterization only. Count and percentage of revascularizations for patients in each of the 4 groups were reported.
Contingency tables and disagreement rates were also presented to assess agreement between sites and QCA separately for each coronary vessel. Each of the 18 segments analyzed was included in the corresponding vessel as per convention. Finally, the agreement was evaluated separately for each of the 2 groups based on the initial test performed-functional vs anatomical. All statistical analyses were performed with SAS version 9.4 (SAS, Cary, NC).
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Results

Study population
Of the 10,003 patients with symptoms suggestive of CAD randomized as part of the PROMISE trial, a site-performed cardiac catheterization report (detailing visual stenosis observed) was available for 1,018 (10.2%), of whom 929 patients had a corresponding paired angiogram available for QCA. The final study population consisted of these 929 patients (9.3% of the overall population) as shown in Figure 1 . Data comparing baseline characteristics between the total PROMISE population, QCA population, and non-QCA population are presented in Supplementary Table I .
Baseline characteristics
Baseline characteristics of patients, stratified by the entire QCA population, patients for whom site and QCA agreed on the presence of obstructive disease, patients for whom site and QCA agreed on the absence of obstructive disease, and patients for whom site and QCA disagreed are summarized in Table I . In general, patients across all groups had more than 2 cardiovascular risk factors, and the prevalences of the individual risk factors were similar across groups. The mean pretest likelihood of obstructive disease according to a combined Diamond-Forrester and Coronary Artery Surgery Study model 16 was higher in patients for whom site and QCA agreed on the presence of obstructive disease (67.4%), as compared with patients for whom site and QCA agreed on the absence of obstructive disease (58.2%), and patients for whom site and QCA disagreed (59.4%).
Results of initial test (functional vs anatomical) at baseline
Of the 929 patients, 532 patients (57.3%) received CTA as the initial test, whereas 373 (40.2%) received a functional test as the initial test (Supplementary Table II ). The 24 (2.6%) remaining patients underwent catheterization without a preceding noninvasive test. Of the patients for whom site and QCA agreed on the presence of obstructive disease, 68.9% had a positive CTA result (N50% stenosis) and 80.0% had a positive functional test result, with evidence of mild, moderate, or severe abnormality/ischemia. Comparatively, 44.5% of patients for whom site and QCA agreed on the absence of obstructive disease had a positive CTA result, and 59.4% had a positive functional test result.
Site-reported stenosis compared with QCA results: disagreement rates
Overall, the sites found obstructive disease on catheterization in 593 patients, whereas QCA found obstructive disease in 428 patients. The rate of disagreement between site reports and QCA results for the presence of obstructive disease is presented in Table II . Of the 929 patients, the site and QCA results agreed in 752 patients (agreement rate of 80.9%) and disagreed in 177 patients (disagreement rate of 19.1%), with an overall κ = 0.63 for agreement (95% CI 0.58-0.67). Of the 177 patients with disagreement, in all but 6 patients, the sites reported obstructive disease, whereas QCA did not. Because the group of patients with coronary stenosis by QCA but no stenosis by site report was small (n = 6 patients), we have limited further discussion of this group. (See Table III .)
Disagreement rates for individual vessels
The rate of agreement and disagreement between site and QCA results was determined for each of the 3 major coronary arteries and the LM (Table III) . The rate of disagreement between sites and QCA for obstructive disease was highest for the LAD (24.1%; overall κ = 0.51, 95% CI 0.46-0.56) and lowest for the LM (3.4%; (κ was not reported for the LM analysis given the small number of patients with disagreement and the disproportionately high number of patients with no obstructive disease in the LM).
Disagreement rates by initial testing strategy
As reported in Table IV , the rate of disagreement between sites and QCA for obstructive disease was higher for patients who received an anatomic test (disagreement rate of 23.3%; overall κ = 0.52, 95% CI 0.45-0.58) than for patients who received a functional test (13.7%; overall κ = 0.72, 95% CI 0.66-0.79).
Site-reported stenosis compared with QCA results: event rates and revascularization rates At 1 year, the primary end point of death, MI, unstable angina hospitalization, or major complications from cardiovascular procedures/testing occurred in 8.3% of the patients in whom both sites and QCA found disease, 4.7% of the patients in whom sites found disease but QCA did not, and 1.5% of the patients in whom neither sites nor QCA found disease. In patients for whom both sites and QCA agreed on presence of disease, the event rates included death (2.8%), MI (1.4%), and hospitalizations for unstable angina (3.6%). A Kaplan-Meier plot for the primary end point showed that unadjusted 1-year primary end point event rates were highest (5.1%) when QCA and sites assessment agreed on presence of obstructive disease, lowest (0.9%) when QCA and sites agreed on absence of obstructive disease, and intermediate (3.1%) when sites found disease but QCA did not (Figure 2A) . Event rates for the composite of death and MI were higher when QCA and sites agreed on presence of obstructive disease and lower when QCA and sites either disagreed on presence or agreed on absence of obstructive disease ( Figure 2B ).
The rate of revascularization at 30 days was highest in patients who had obstructive disease according to both Derivation of study population from total PROMISE trial population. cath, catheterization.
site reports and QCA (80.8%) (Table V) , but was only 48.0% when sites found obstructive disease but QCA did not. In patients with obstructive disease per site reports, revascularization rates were higher when QCA found obstructive disease than when QCA found no obstructive disease (percutaneous coronary intervention: 64.2% vs 39.2%; coronary artery bypass graft: 18.7% vs 8.8%).
Discussion
This substudy of the PROMISE trial compared visually estimated coronary artery stenosis with independent, blinded QCA analysis of the corresponding coronary angiographic images in 929 patients with symptomatic chest pain who underwent an invasive coronary catheterization as part of their diagnostic work-up. The results from this study identify the following 4 major findings. First, visual estimation of stenosis has a higher rate of finding obstructive coronary lesions when compared with QCA. Second, cardiovascular event rates and revascularization rates were high in patients for whom QCA and visual estimation were concordant for obstructive disease and low in patients in whom neither method diagnosed obstructive CAD. Third, the disagreement between visual estimation of stenosis and QCA was most pronounced for the LAD. Finally, contrary to expectations, when visual estimation reported obstructive disease and QCA did not, the cardiovascular event rates were intermediate between those with concordance for disease and concordance for no obstructive disease.
In our analyses, we found that visual reads noted the presence of obstructive disease more frequently when compared with QCA. This finding is consistent with prior studies, which have shown that physicians "overestimate" lesion severity during visual reading of angiograms when compared with QCA methods. 7, 9, 10 These previous studies were generally performed in patients undergoing percutaneous coronary intervention, and thus, all had significant coronary stenosis. This study expands these findings to suggest that visual estimation of lesion severity overestimates lesions across all levels of stenosis when compared with QCA. The reasons why visual estimation routinely overestimates stenosis are likely multifold. It has been suggested that visual observers may have a tendency to assess area stenosis rather than vessel diameter stenosis, 7, 8 although another study did not find this to be the case. 10 It has also been noted that there may be a tendency among visual readers to overestimate stenosis in smaller vessels. 10 In addition, lesion length affecting estimation of true diameter and calcification affecting opacification may lead to overestimation. It must be noted that physiologic prediction of flow from stenosis is also difficult in cases where there are longer lesions, and some of the differences between QCA and visual estimation may stem from this. In theory, QCA might help alleviate some of the above-mentioned sources of error.
Given this disagreement, it is important to question whether visual estimation or QCA is the more accurate method to predict clinical outcomes. In this study, both cardiovascular event rates and rates of revascularization within the first 30 days were lower for patients in whom sites found obstructive disease but QCA did not, compared with patients in whom both the sites and QCA reported disease, suggesting a lower cardiovascular disease risk in this discordant group. Physiologically, as lesion severity increases, even small changes in diameter can have significant physiologic and hemodynamic consequences. However, given that event rates were higher in the discordant group than when both methods did not find obstructive disease, visual stenosis even in the absence of positive QCA may identify patients with residual cardiovascular risk.
The enhanced prognostic implications of site-reported data in this intermediate group could be due to the inability of QCA to account for other factors that may be identified by the procedure-performing physician upon clinical evaluation of the patient. Our findings likely indicate some degree of integration of the patient's clinical presentation and precatheterization information with visual stenosis at time of angiography. Furthermore, the presence of typical angina, results of functional testing, and additional lesion-specific information from intravascular ultrasound or fractional flow reserve (which were not available during QCA analysis) could have been factored into the visual assessment of lesion stenosis and the decision for revascularization. Disagreement may also be in part due to the fact that QCA stenosis does not take into account factors such as inferior angiogram quality/ haziness that may influence clinicians' decisions. However, as noted above, visual estimation too is not perfect, and in cases where clinical and angiographic data conflict, invasive coronary physiology testing with fractional flow reserve and/or instantaneous wave-free ratio should be used for an accurate assessment.
The rate of disagreement between sites and QCA was greatest for the LAD, intermediate for the right coronary artery and left circumflex artery, and lowest for the LM. Although the paucity of LM stenosis may explain the low result, the reason for a higher rate of disagreement in the ⁎ Disagreement is defined as when site and core laboratory responses are not equal. † κ not reported given a small number of patients with disagreement and disproportionately high number of patients with no disease compared with patients with disease in LM.
LAD is less evident. A possible explanation might be the length of these arteries. The QCA data include the proximal, medial, and distal parts of the LAD as well as the major branches of the LAD. The long length of the LAD, with multiple branches covering a large territory, potentially affects assessment. It may also be that physicians' assessments of stenosis are influenced by the known higher clinical risk associated with LAD lesions compared with other vessels. Our findings suggest the opportunity for invasive physiologic testing to improve characterization of all the major coronary vessels, especially the LAD. Finally, the rate of disagreement between visually estimated stenosis and QCA was higher for patients who received an anatomic test initially (ie, CTA) when compared with patients who received a functional test. This result may be surprising to some who may expect the use of CTA to lead to better correlation for determination of obstructive disease. A possible explanation is that although CTA, similar to angiography, provides an anatomic visualization of the artery, a functional test may provide additional information regarding the patient's clinical status that may help the physician better evaluate the angiographic lesion in the context of the patient's overall clinical status. Alternatively, the site physicians who interpreted invasive angiography may have been influenced by the stenosis reported on CTA, again providing an opportunity for improvement with either noninvasive or invasive physiologic measures.
Limitations
This is a post hoc analysis of the PROMISE population and should be regarded as hypothesis generating rather than definitive. As such, this study was not powered to demonstrate a specific difference in patient subsets for disagreement between site-reported stenosis and QCA results. Quantitative coronary angiography has its own limitations that have been previously noted, 9, 17 including that QCA does require a minimal amount of user input, albeit less than visual stenosis estimation, and as such is not free from user variability.
Conclusion
Our study finds that routine visual estimation of angiograms notes the presence of obstructive CAD with a higher frequency than QCA. Visual estimation and QCA agreement on presence of obstructive CAD were associated with higher cardiovascular event rates and revascularization rates, and agreement for no obstructive CAD was associated with low event and revascularization rates. However, obstructive disease present by site visual estimation and absent by QCA was associated with intermediate rates. These findings suggest that opportunities exist to improve the routine interpretation of coronary angiography. Given the limitations of angiography, a strong case can be made for the increased use of invasive coronary physiology testing to arbitrate and guide management in patients with moderate coronary disease.
